Cortés, Kamila Caraballo <br/><br/>
Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcome.  [electronic resource] 

 -  BMC infectious diseases  Jul 2014 
 - 389 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2334 
<br/><br/><label>Standard No.: </label>10.1186/1471-2334-14-389  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--therapeutic use<br/>Base Sequence<br/>Female<br/>Genetic Heterogeneity<br/>Genetic Variation<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use<br/>Treatment Outcome<br/>Viral Envelope Proteins--genetics